Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Short Interest Down 85.6% in July

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totaling 4,306 shares, a decline of 85.6% from the June 30th total of 29,843 shares. Currently, 0.4% of the shares of the company are short sold. Based on an average daily volume of 11,693 shares, the short-interest ratio is currently 0.4 days.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Prime Capital Investment Advisors LLC bought a new stake in shares of Virtus LifeSci Biotech Products ETF in the fourth quarter valued at approximately $1,896,000. Flow Traders U.S. LLC bought a new position in Virtus LifeSci Biotech Products ETF during the second quarter worth $431,000. Finally, Comprehensive Financial Planning Inc. PA bought a new position in Virtus LifeSci Biotech Products ETF during the fourth quarter worth $557,000.

Virtus LifeSci Biotech Products ETF Price Performance

Shares of NYSEARCA BBP traded down $0.87 during trading hours on Friday, hitting $96.39. 1,927 shares of the company’s stock were exchanged, compared to its average volume of 8,109. The company’s 50-day moving average price is $91.90 and its 200-day moving average price is $86.46. Virtus LifeSci Biotech Products ETF has a 1-year low of $60.91 and a 1-year high of $105.21.

Virtus LifeSci Biotech Products ETF Company Profile

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.